Remember When Pharmaceutical Marketing Was Relatively Simple? Between physicians, patients, pharmaceutical companies, pharmacists, marketing managers, payors and the FDA, the conversation isn’t so simple anymore. Are current communications meeting the needs of all these stakeholders? Is there a fix? What’s ahead? Find out how our industry’s conversation has changed direction and scope, and if we have the tools to deal with this dynamic challenge. See what pharmaceutical marketing expert Al Topin has to say on the subject in his insightful article and his video presentation.
Let other members of the Pharmaceutical Executive audience know what you think. Join the conversation on Al Topin is President of Topin & Associates, and a member of Pharmaceutical Executive’s Editorial Advisory Board. He can be reached at atopin@topin.com. |
